Remedy GPO

Remedy GPO will be exhibiting at two upcoming conferences!✈️ 🧠 CMSC Annual Meeting | May 27–29 | Charlotte, NC 🌿 Eastern Allergy Conference | May 28–31 | Palm Beach, FL Attending? Stop by our booth to learn how we support specialty practices.

When infusion no-shows and late cancellations 🚫occur, the effects extend beyond a single missed appointment, contributing to underutilized capacity, operational inefficiencies, and potential disruptions in patient continuity of care. ➡️ Read more: remedygpo.com/reducing-infus…

📍Remedy GPO is set up and ready at The New Jersey Rheumatology Association Annual Spring Meeting! Stop by our booth to discuss your practice needs and learn how Remedy GPO membership can support your goals. 👋

➡️ Remedy GPO is heading to NJRA 2026 Spring Meeting and @atscommunity (ATS) 2026 next week! Attending? Stop by our booths or reach out to schedule a meeting & learn more about our member benefits, purchasing opportunities, operational resources & practice-focused services. 👋

Remedy GPO is headed to the 🧠 Massachusetts Neurologic Association Annual Meeting in Cambridge, MA on 5/9! 📍Stop by our booth to meet Jeff Cook & learn more about our member-based services for specialty providers, including resources to support practice growth.

Remedy GPO is looking forward to exhibiting at two upcoming conferences: 📍 CCR East 2026 | Destin, FL | April 30-May 2 📍 DDW 2026 | Chicago, IL | May 2-5 Attending? Stop by our booth to meet the team!

🧠 Remedy GPO is set up and ready for the 2026 @AANmember Annual Meeting in Chicago, IL! Stop by our booth to meet our team and learn how our solutions for 🏥 in-office infusion providers can support high-quality patient care and strengthen practice performance.

In January, CMS selected 15 additional drugs 💊 for Medicare negotiation for 2028, including the first drugs payable under Part B. For 📋 buy-and-bill infusion providers, that shifts the conversation from policy awareness to early operational planning. remedygpo.com/the-next-front…

Thanks to everyone who stopped📍by our booths this past weekend at SCRS in Charleston and TAAIS in Cedar Creek. We loved connecting with providers about how Remedy GPO helps specialty practices improve purchasing efficiency, strengthen operations, and support patient care. 🏥

Remedy GPO is headed to the 🧠 2026 @AANmember Annual Meeting, April 18–22 in Chicago. 👋 Stop by our booth to meet Charles, Patricia, Michelle, and Jeff and learn how we support in-office infusion providers and patients receiving biologics.

Patient experience data 📊 has become an increasingly valuable tool for infusion practices seeking to improve performance in a competitive and patient-centered care environment. remedygpo.com/harnessing-pat…

For independent specialty practices, 2026 PBM formulary 💊 updates have practical implications for therapy access, reimbursement predictability, and purchasing strategy. 👉 Read more: remedygpo.com/2026-pbm-formu…

Heading to the 2026 STAR Annual Meeting? 🌟 If you’re a rheumatology provider with in-office infusion, let’s connect. 👋 Meet Sales Director Patricia LaZar to talk GPO strategy, infusion optimization & protecting practice margin. 🗓️Feb 20-22 📍DM us to schedule time

🧠 Understanding where biologic volatility originates & how to contain it has become a critical operational priority for neurology practice owners & admins, and an area where experienced group purchasing organizations provide essential strategic support. remedygpo.com/the-hidden-fin…

Rituximab remains a cornerstone biologic for many autoimmune rheumatic diseases. Traditional protocols recommend a ⏰ slow infusion, often 3.5–4+ hours. However, a growing body of evidence supports ↗️ accelerated infusion protocols after the initial dose. remedygpo.com/faster-rituxim…

In 2026, the challenge for specialty practice infusion centers is no longer whether demand exists, but how efficiently ✅ existing resources are used. Read more: remedygpo.com/optimizing-inf…

Biosimilars now influence acquisition cost, reimbursement strategy, and patient continuity of care. Understanding these 📈 market forces, especially payer behavior, is essential for maintaining operational and financial stability. 👉 Read more: remedygpo.com/biosimilar-ado…

👉 The buy-and-bill ecosystem is undergoing its most dramatic shift in a decade. Vertical integration ↕️ alters incentives across the specialty landscape and reshapes specialty drug economics, directly affecting independent practices. Read more: remedygpo.com/vertical-integ…

For specialty providers, drug procurement is more than a 🔀 supply chain task; it’s a financial and operational cornerstone. remedygpo.com/optimizing-dru…

Remedy GPO will be exhibiting 🌟 at the RPPA Growth Summit in Houston, Nov 7–9! Stop by our booth to meet Sales Director Charles Taylor and learn how we support rheumatology practices with member-based services that enhance care and drive growth. See you there! 👋